Recombinant activated factor VII for treatment of enoxaparin-induced bleeding.
Hu
Qiyue
Q
Brady
James O
JO
D000368:Aged; D017984:Enoxaparin / Q000009:adverse effects*; D015942:Factor VIIa / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
D017984:Enoxaparin; D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D015942:Factor VIIa